Michael H. Davidson - Publications, H-index & Citations

Michael H. Davidson

university of amsterdam

93H指数

642论文数

3.5W被引数

收录论文 191

发表时间

Novel cholesterol lowering drugs: Can phase 2/3 clinical trial safety assessments predict cardiovascular event outcome trial efficacy?新型降胆固醇药物：Ⅱ/Ⅲ期临床试验安全性评估能否预测心血管事件结局试验的有效性？

AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE

IF1.8

2026-02-01

OAAI

Shear, Charles; Davidson, Michael H.; Ditmarsch, Marc; Kastelein, John J. P.; Szarek, Michael

Pharmacotherapy Development and Trends in Lipidology: An Expert Discussion 脂质学中的药物疗法开发与趋势：专家讨论

Journal of Clinical Lipidology

IF4.6

2025-10-10

OAAI

Michael H. Davidson; Kevin C. Maki

Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients 奥比他平对高危患者主要心血管不良事件的影响

JACC

IF0

2025-09-01

OAAI

Stephen J. Nicholls; Adam J. Nelson; Kausik K. Ray; Christie M. Ballantyne; Marc Ditmarsch; Douglas Kling; Andrew Hsieh; Michael Szarek; John J. Kastelein; Michael H. Davidson

A Drug–Drug Interaction Study Evaluating the Pharmacokinetic Consequences of Obicetrapib Therapy on Atorvastatin or Rosuvastatin Levels in Healthy Volunteers 一项药物-药物相互作用研究，评估Obicetrapib疗法对健康受试者中阿托伐他汀或罗苏伐他汀水平药代动力学影响的研究。

American Journal of Cardiovascular Drugs

IF3

2025-06-26

OAAI

John J. P. Kastelein; Marc Ditmarsch; Andrew Hsieh; Douglas Kling; Ashley Walker; Mary R. Dicklin; Zia Tayab; Mohammed Bouhajib; Michael H. Davidson

Obicetrapib lowers LDL-cholesterol by substantially increasing LDL-ApoB clearance rates in humans Obicetrapib通过显著增加人类LDL-ApoB清除率来降低LDL-胆固醇。

Journal of Clinical Lipidology

IF4.6

2025-05-29

PREAI

Archna Bajaj; John Millar; Marc Ditmarsch; John JP KasteleinPhD; Erin Wuerdeman; Douglas Kling; Michael H Davidson; Daniel Rader

Obicetrapib Demonstrates Significant Deductions of LP(A) on Top of High-Intensity Statins

AMERICAN HEART JOURNAL

IF3.5

2024-12-01

PREAI

Tsimikas, S.; Yang, X.; Hsieh, A.; Ditmarsch, M.; Davidson, M.; Kastelein, J.

Cholesteryl ester transfer protein inhibition: a pathway to reducing risk of morbidity and promoting longevity

CURRENT OPINION IN LIPIDOLOGY

IF4.6

2024-10-17

OAAI

Davidson, Michael H.; Hsieh, Andrew; Kastelein, John J. P.

Lower activity of cholesteryl ester transfer protein (CETP) and the risk of dementia: a Mendelian randomization analysis 胆固醇酯转移蛋白 (CETP) 的较低活性和痴呆的风险: 孟德尔随机化分析

ALZHEIMERS RESEARCH & THERAPY

IF7.6

2024-10-16

OAAI

Schmidt, Amand F.; Davidson, Michael H.; Ditmarsch, Marc; Kastelein, John J.; Finan, Chris

Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN 在动脉粥样硬化性心血管疾病或高风险参与者中，Obicetrapib在最大耐受的脂质修饰疗法之上: 百老汇和布鲁克林的原理和设计

AMERICAN HEART JOURNAL

IF3.5

2024-08-01

OAAI

Nicholls, Stephen J.; Nelson, Adam J.; Ditmarsch, Marc; Kastelein, John J. P.; Ballantyne, Christie M.; Ray, Kausik K.; Navar, Ann Marie; Nissen, Steven E.; Golberg, Anne C.; Brunham, Liam R.; Curcio, Danielle; Wuerdeman, Erin; Neild, Annie; Kling, Douglas; Hsieh, Andrew; Dicklin, Mary R.; Ference, Brian A.; Laufs, Ulrich; Banach, Maciej; Mehran, Roxana; Catapano, Alberico L.; Davidson, Michael H.

The Imperative to Enhance Cost-Effectiveness for Cardiovascular Therapeutic Development

JACC-BASIC TO TRANSLATIONAL SCIENCE

IF7.2

2024-08-01

OAAI

Davidson, Michael H.; Hsieh, Andrew; Dicklin, Mary R.; Maki, Kevin C.

CETP and SGLT2 inhibitor combination therapy increases glycemic control: a 2x2 factorial Mendelian randomization analysis

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2024-06-19

OAAI

Khomtchouk, Bohdan B.; Sun, Patrick; Maggio, Zane A.; Ditmarsch, Marc; Kastelein, John J. P.; Davidson, Michael H.

Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments

CURRENT ATHEROSCLEROSIS REPORTS

IF5.2

2023-12-22

OAAI

Kastelein, John J. P.; Hsieh, Andrew; Dicklin, Mary R.; Ditmarsch, Marc; Davidson, Michael H.

Real-World Effectiveness and Safety of Evinacumab in Pediatric and Adult Patients With Homozygous Familial Hypercholesterolemia: A Multi-Site US Perspective

CIRCULATION

IF38.6

2023-11-07

PREAI

Wilkinson, Michael J.; Bijlani, Priyesha; Davidson, Michael H.; Duell, P. B.; Horan, Mary; Malloy, Mary J.; Newfield, Ron; Pradeep, Pallavi; Sam, Colleen; Shah, Prediman K.; Stock, Eveline O.; Warden, Bruce; Ito, Matthew K.

Obicetrapib as an Adjunct to Stable Statin Therapy Significantly Lowers LDL-C, Non-HDL-C, and Apolipoprotein B in Japanese Patients: Results From the Japan Phase 2 Study

CIRCULATION

IF38.6

2023-11-07

PREAI

Harada-Shiba, Mariko; Kling, Douglas; Kastelein, John J.; Ditmarsch, Marc; Wuerdeman, Erin; Hsieh, Andrew; Nicholls, Stephen; Davidson, Michael

A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2023-08-01

PREAI

Weiser, Mark; Levi, Linda; Park, Jinyoung; Nastas, Igor; Matei, Valentin; Davidson, Michael; Arad, Ido; Dudkiewicz, Israel; Davis, John M.

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

JOURNAL OF CLINICAL LIPIDOLOGY

IF4.6

2023-07-01

OAAI

Ballantyne, Christie M.; Ditmarsch, Marc; Kastelein, John J. P.; Nelson, Adam J.; Kling, Douglas; Hsieh, Andrew; Curcio, Danielle L.; Maki, Kevin C.; Davidson, Michael H.; Nicholls, Stephen J.

Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio A Secondary Analysis of the RESCUE Clinical Trial

JAMA CARDIOLOGY

IF14.1

2023-02-01

OAAI

Adamstein, Nicholas H.; Cornel, Jan Hein; Davidson, Michael; Libby, Peter; de Remigis, Alessandra; Jensen, Camilla; Ekstroem, Kathrine; Ridker, Paul M.

Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine-Brief Report

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2022-12-01

OAAI

Deshotels, Matthew R.; Hadley, Trevor D.; Roth, Mendel; Agha, Ali M.; Pulipati, Vishnu Priya; Nugent, Anne K.; Virani, Salim S.; Nambi, Vijay; Moriarty, Patrick M.; Davidson, Michael H.; Ballantyne, Christie M.

Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY

IF6.1

2022-10-28

OAAI

Martin, Seth S.; Ditmarsch, Marc; Simmons, Mark; Alp, Nicholas; Turner, Traci; Davidson, Michael H.; Kastelein, John J. P.

Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial CETP抑制剂obicetrapib联合高强度他汀类药物的降脂作用: 一项随机2期试验

NATURE MEDICINE

IF50

2022-08-11

OAAI

Nicholls, Stephen J.; Ditmarsch, Marc; Kastelein, John J.; Rigby, Scott P.; Kling, Douglas; Curcio, Danielle L.; Alp, Nicholas John; Davidson, Michael H.

研究方向